AMANDA MARSHBURN: Open Payments
NPI 1003362765 · RICHLANDS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 11 payments from 8 companies in 2025. Trend: 2023 $163 · 2024 $345 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Medtronic, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $20 |
| Novo Nordisk Inc | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
| PFIZER INC. | 1 | $15 |
Products named: GEMTESA, TRELEGY ELLIPTA, INCEPTIV, Veozah, Wegovy, BREZTRI, The Cologuard Plus Collection Kit, ELIQUIS.
Industry payments across NC — which companies pay providers there.
